Home/Filings/4/0001181431-05-033434
4//SEC Filing

CLOSURE MEDICAL CORP 4

Accession 0001181431-05-033434

CIK 0001016006operating

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 3:37 PM ET

Size

23.0 KB

Accession

0001181431-05-033434

Insider Transaction Report

Form 4
Period: 2005-06-03
SZABO GABRIEL N
VP of Product Development
Transactions
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-06-03$12.44/sh20,000$248,8000 total
    Exercise: $14.56Exp: 2009-09-15Common Stock (20,000 underlying)
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-06-03$12.13/sh2,000$24,2500 total
    Exercise: $14.88Exp: 2011-03-26Common Stock (2,000 underlying)
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-06-03$7.13/sh8,000$57,0000 total
    Exercise: $19.88Exp: 2010-09-11Common Stock (8,000 underlying)
  • Disposition to Issuer

    Common Stock

    2005-06-03$27.00/sh2,691$72,6570 total
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-06-03$3.51/sh2,200$7,7220 total
    Exercise: $23.49Exp: 2012-01-02Common Stock (2,200 underlying)
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-06-03$7.95/sh18,000$143,1000 total
    Exercise: $19.05Exp: 2014-12-20Common Stock (18,000 underlying)
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-06-03$4.74/sh10,000$47,4000 total
    Exercise: $22.26Exp: 2013-06-11Common Stock (10,000 underlying)
Footnotes (4)
  • [F1]Amount includes shares acquired under the Employee Stock Purchase Plan at various times and disposed of pursuant to the merger agreement between Closure Medical Corporation, Johnson & Johnson and Holden Merger Sub, Inc., a wholly owned subsidiary of Johnson & Johnson, in exchange for a cash payment of $27 per share on the effective date of the merger.
  • [F2]This option, which provided for vesting in five equal installments commencing on the first anniversary of the date of the grant, was canceled in the merger pursuant to the terms of the merger agreement between Closure Medical Corporation, Johnson & Johnson and Holden Merger Sub, Inc., a wholly owned subsidiary of Johnson & Johnson, in exchange for a cash payment equal to the difference between $27 and the exercise price of the option.
  • [F3]This option, which provided for vesting in three equal installments when each of three increasing stock market prices were achieved, or in any event, in five equal installments commencing on the first anniversary of the date of the grant, was canceled in the merger pursuant to the terms of the merger agreement between Closure Medical Corporation, Johnson & Johnson and Holden Merger Sub, Inc., a wholly owned subsidiary of Johnson & Johnson, in exchange for a cash payment equal to the difference between $27 and the exercise price of the option.
  • [F4]This option, which provided for vesting in four equal installments commencing on the first anniversary of the date of the grant, was canceled in the merger pursuant to the terms of the merger agreement between Closure Medical Corporation, Johnson & Johnson and Holden Merger Sub, Inc., a wholly owned subsidiary of Johnson & Johnson, in exchange for a cash payment equal to the difference between $27 and the exercise price of the option.

Issuer

CLOSURE MEDICAL CORP

CIK 0001016006

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001016006

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 3:37 PM ET
Size
23.0 KB